Acute stress responsiveness of the neurotrophin bdnf in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine

Raffaella Molteni, Francesca Calabrese, Annamaria Cattaneo, Michele Mancini, Massimo Gennarelli, Giorgio Racagni, Marco A. Riva

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Compelling evidence suggests that mood disorders are characterized by reduced neuronal plasticity that might be normalized by pharmacological intervention. Our study aimed to establish whether chronic antidepressant treatment could alter the modulation of the neurotrophin brain-derived neurotrophic factor (BDNF) under a stressful condition. Therefore, adult male Sprague-Dawley rats were treated for 21 days with vehicle or with the SNRI duloxetine and, 24 h after the last injection, exposed to an acute swim stress (5 min) before being killed 15 min later. We found that chronic duloxetine treatment was able to modulate the rapid transcriptional changes of BDNF isoforms produced by an acute swim stress. Indeed whereas the mRNA levels of BDNF exon IV were upregulated by stress in vehicle as well as in duloxetine-treated rats, a significant increase of exon VI and exon IX was only found in rats that were pretreated with the antidepressant. These differential effects are in part because of selective changes in signaling pathways involved in the control of BDNF transcription. Moreover, the acute stressful episode significantly increased the levels of mature BDNF protein in the synaptosomal compartment in rats that were pretreated with the antidepressant, but not in control animals. Our results suggest that chronic antidepressant treatment might affect the responsiveness of BDNF under stressful conditions, suggesting that pharmacological intervention could prime neuroprotective pathways and render them more responsive to preserve cell function and viability.

Original languageEnglish
Pages (from-to)1523-1532
Number of pages10
JournalNeuropsychopharmacology
Volume34
Issue number6
DOIs
Publication statusPublished - May 2009

Fingerprint

Brain-Derived Neurotrophic Factor
Nerve Growth Factors
Antidepressive Agents
Hippocampus
Exons
Therapeutics
Pharmacology
Neuronal Plasticity
Mood Disorders
Sprague Dawley Rats
Duloxetine Hydrochloride
Cell Survival
Protein Isoforms
Messenger RNA
Injections

Keywords

  • Antidepressant
  • Glucocorticoid receptor
  • Hippocampus
  • Neuroplasticity
  • Stress

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Acute stress responsiveness of the neurotrophin bdnf in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. / Molteni, Raffaella; Calabrese, Francesca; Cattaneo, Annamaria; Mancini, Michele; Gennarelli, Massimo; Racagni, Giorgio; Riva, Marco A.

In: Neuropsychopharmacology, Vol. 34, No. 6, 05.2009, p. 1523-1532.

Research output: Contribution to journalArticle

Molteni, Raffaella ; Calabrese, Francesca ; Cattaneo, Annamaria ; Mancini, Michele ; Gennarelli, Massimo ; Racagni, Giorgio ; Riva, Marco A. / Acute stress responsiveness of the neurotrophin bdnf in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. In: Neuropsychopharmacology. 2009 ; Vol. 34, No. 6. pp. 1523-1532.
@article{766733b1c67a4ea99c529cc8f5ae270e,
title = "Acute stress responsiveness of the neurotrophin bdnf in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine",
abstract = "Compelling evidence suggests that mood disorders are characterized by reduced neuronal plasticity that might be normalized by pharmacological intervention. Our study aimed to establish whether chronic antidepressant treatment could alter the modulation of the neurotrophin brain-derived neurotrophic factor (BDNF) under a stressful condition. Therefore, adult male Sprague-Dawley rats were treated for 21 days with vehicle or with the SNRI duloxetine and, 24 h after the last injection, exposed to an acute swim stress (5 min) before being killed 15 min later. We found that chronic duloxetine treatment was able to modulate the rapid transcriptional changes of BDNF isoforms produced by an acute swim stress. Indeed whereas the mRNA levels of BDNF exon IV were upregulated by stress in vehicle as well as in duloxetine-treated rats, a significant increase of exon VI and exon IX was only found in rats that were pretreated with the antidepressant. These differential effects are in part because of selective changes in signaling pathways involved in the control of BDNF transcription. Moreover, the acute stressful episode significantly increased the levels of mature BDNF protein in the synaptosomal compartment in rats that were pretreated with the antidepressant, but not in control animals. Our results suggest that chronic antidepressant treatment might affect the responsiveness of BDNF under stressful conditions, suggesting that pharmacological intervention could prime neuroprotective pathways and render them more responsive to preserve cell function and viability.",
keywords = "Antidepressant, Glucocorticoid receptor, Hippocampus, Neuroplasticity, Stress",
author = "Raffaella Molteni and Francesca Calabrese and Annamaria Cattaneo and Michele Mancini and Massimo Gennarelli and Giorgio Racagni and Riva, {Marco A.}",
year = "2009",
month = "5",
doi = "10.1038/npp.2008.208",
language = "English",
volume = "34",
pages = "1523--1532",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Acute stress responsiveness of the neurotrophin bdnf in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine

AU - Molteni, Raffaella

AU - Calabrese, Francesca

AU - Cattaneo, Annamaria

AU - Mancini, Michele

AU - Gennarelli, Massimo

AU - Racagni, Giorgio

AU - Riva, Marco A.

PY - 2009/5

Y1 - 2009/5

N2 - Compelling evidence suggests that mood disorders are characterized by reduced neuronal plasticity that might be normalized by pharmacological intervention. Our study aimed to establish whether chronic antidepressant treatment could alter the modulation of the neurotrophin brain-derived neurotrophic factor (BDNF) under a stressful condition. Therefore, adult male Sprague-Dawley rats were treated for 21 days with vehicle or with the SNRI duloxetine and, 24 h after the last injection, exposed to an acute swim stress (5 min) before being killed 15 min later. We found that chronic duloxetine treatment was able to modulate the rapid transcriptional changes of BDNF isoforms produced by an acute swim stress. Indeed whereas the mRNA levels of BDNF exon IV were upregulated by stress in vehicle as well as in duloxetine-treated rats, a significant increase of exon VI and exon IX was only found in rats that were pretreated with the antidepressant. These differential effects are in part because of selective changes in signaling pathways involved in the control of BDNF transcription. Moreover, the acute stressful episode significantly increased the levels of mature BDNF protein in the synaptosomal compartment in rats that were pretreated with the antidepressant, but not in control animals. Our results suggest that chronic antidepressant treatment might affect the responsiveness of BDNF under stressful conditions, suggesting that pharmacological intervention could prime neuroprotective pathways and render them more responsive to preserve cell function and viability.

AB - Compelling evidence suggests that mood disorders are characterized by reduced neuronal plasticity that might be normalized by pharmacological intervention. Our study aimed to establish whether chronic antidepressant treatment could alter the modulation of the neurotrophin brain-derived neurotrophic factor (BDNF) under a stressful condition. Therefore, adult male Sprague-Dawley rats were treated for 21 days with vehicle or with the SNRI duloxetine and, 24 h after the last injection, exposed to an acute swim stress (5 min) before being killed 15 min later. We found that chronic duloxetine treatment was able to modulate the rapid transcriptional changes of BDNF isoforms produced by an acute swim stress. Indeed whereas the mRNA levels of BDNF exon IV were upregulated by stress in vehicle as well as in duloxetine-treated rats, a significant increase of exon VI and exon IX was only found in rats that were pretreated with the antidepressant. These differential effects are in part because of selective changes in signaling pathways involved in the control of BDNF transcription. Moreover, the acute stressful episode significantly increased the levels of mature BDNF protein in the synaptosomal compartment in rats that were pretreated with the antidepressant, but not in control animals. Our results suggest that chronic antidepressant treatment might affect the responsiveness of BDNF under stressful conditions, suggesting that pharmacological intervention could prime neuroprotective pathways and render them more responsive to preserve cell function and viability.

KW - Antidepressant

KW - Glucocorticoid receptor

KW - Hippocampus

KW - Neuroplasticity

KW - Stress

UR - http://www.scopus.com/inward/record.url?scp=64949143171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64949143171&partnerID=8YFLogxK

U2 - 10.1038/npp.2008.208

DO - 10.1038/npp.2008.208

M3 - Article

VL - 34

SP - 1523

EP - 1532

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 6

ER -